Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.15
-0.11 (-0.90%)
At close: Oct 30, 2026, 4:00 PM EDT
12.17
+0.02 (0.16%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Medifast Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
72.0576.3876.0475.189.41105.56115.73119140.16168.56174.74191.02235.87296.19348.98337.25390.4453.33417.6377.83
Revenue Growth (YoY)
-19.42%-27.64%-34.29%-36.90%-36.21%-37.38%-33.77%-37.70%-40.58%-43.09%-49.93%-43.36%-39.58%-34.66%-16.43%-10.74%-5.56%15.00%22.58%42.63%
Cost of Revenue
22.0122.9924.2922.9627.2528.9131.4830.7834.4945.1247.4549.6558.4985.47102.5991.45107.55131.65115.3199.55
Gross Profit
50.0453.451.7652.1462.1676.6484.2588.22105.67123.44127.29141.37177.38210.72246.39245.79282.85321.68302.29278.29
Selling, General & Admin
66.657.7256.1458.9465.1477.7184.4173.71102.47130.21118.35131.49150.57170.91191.88199.8233.59271.52246.3230.35
Research & Development
2.8-1.111.1-1.11.31.11.111.21.31.111.21.11.20.91.1
Operating Expenses
69.457.7257.2459.9466.2477.7185.5175.01103.57131.31119.35132.69151.87172.01192.88201234.69272.72247.2231.45
Operating Income
-19.36-4.33-5.48-7.8-4.08-1.07-1.2613.212.11-7.887.948.6825.5138.7153.5144.7948.1648.9655.0946.84
Interest Expense
---------------0.18-0.18-0.26-0.16-0.1-0.09
Interest & Investment Income
1.511.351.381.421.431.371.30.951.331.31.221.181.030.46------
Other Non Operating Income (Expenses)
0.02-0.010.020-02.57-0.14-0.39-1.86-4.072.42-0.050.01-0.05-0-0.01-0.02-0-0.020.01
EBT Excluding Unusual Items
-17.84-2.99-4.08-6.38-2.662.88-0.113.781.58-10.6511.599.826.5539.1253.3344.647.8848.854.9846.75
Merger & Restructuring Charges
--------12.5--------12.2----
Gain (Loss) on Sale of Investments
---0.04---0.63-------------
Gain (Loss) on Sale of Assets
--2.18-----------------
Pretax Income
-17.84-2.99-1.94-6.38-2.662.880.531.281.58-10.6511.599.826.5539.1253.3332.4147.8848.854.9846.75
Income Tax Expense
-0.320.110.1811.74-0.40.41.30.470.45-2.53.273.773.428.8413.365.8911.729.6813.212.73
Earnings From Continuing Operations
-17.51-3.1-2.12-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.02
Net Income
-17.51-3.1-2.12-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.02
Net Income to Common
-17.51-3.1-2.12-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.02
Net Income Growth (YoY)
--------86.73%-95.12%--79.19%-77.24%-36.02%-22.58%-4.34%-22.06%-13.88%-16.71%1.75%21.54%
Shares Outstanding (Basic)
1111111111111111111111111111111111111212
Shares Outstanding (Diluted)
1111111111111111111111111111111111111212
Shares Change (YoY)
1.73%0.68%0.53%0.07%0.18%1.13%-0.09%0.44%0.35%0.18%0.54%-0.53%-0.99%-4.53%-6.35%-6.04%-6.30%-3.57%-2.04%-1.45%
EPS (Basic)
-1.57-0.28-0.19-1.65-0.210.23-0.070.070.10-0.750.760.552.122.783.682.433.303.443.622.93
EPS (Diluted)
-1.57-0.28-0.19-1.65-0.210.22-0.070.070.10-0.750.760.552.122.773.672.413.273.423.592.91
EPS Growth (YoY)
--------87.20%-95.28%--79.29%-77.29%-35.17%-19.01%2.23%-17.42%-8.15%-13.64%3.76%23.37%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
2.870.73-0.84-6.6310.75-4.761.88-7.237.6811.135.449.5828.2541.461.9442.6853.6340.9240.66-19.08
Free Cash Flow Per Share
0.260.07-0.08-0.600.98-0.430.17-0.660.701.020.500.882.583.795.683.884.863.583.49-1.63
Dividend Per Share
------------1.6501.6501.6501.6401.6401.6401.6401.420
Dividend Growth (YoY)
------------0.61%0.61%0.61%15.49%15.49%15.49%15.49%25.66%
Gross Margin
69.45%69.91%68.06%69.43%69.52%72.61%72.80%74.13%75.39%73.23%72.85%74.01%75.20%71.14%70.60%72.88%72.45%70.96%72.39%73.65%
Operating Margin
-26.87%-5.67%-7.21%-10.39%-4.56%-1.01%-1.09%11.10%1.50%-4.67%4.54%4.54%10.81%13.07%15.33%13.28%12.34%10.80%13.19%12.40%
Profit Margin
-24.30%-4.06%-2.79%-24.13%-2.53%2.35%-0.67%0.67%0.80%-4.84%4.76%3.16%9.81%10.22%11.45%7.86%9.26%8.63%10.01%9.01%
Free Cash Flow Margin
3.98%0.95%-1.10%-8.83%12.02%-4.51%1.63%-6.08%5.48%6.60%3.11%5.01%11.98%13.98%17.75%12.65%13.74%9.03%9.74%-5.05%
EBITDA
-17-0.88-2-4.34-0.632.982.0216.45.3-4.8111.212.0328.9242.0756.4947.7551.0151.757.5349.88
EBITDA Margin
-23.59%-1.15%-2.63%-5.78%-0.70%2.82%1.74%13.78%3.78%-2.85%6.41%6.30%12.26%14.21%16.19%14.16%13.06%11.40%13.78%13.20%
D&A For EBITDA
2.363.453.483.473.454.053.283.193.193.073.263.353.413.372.972.952.852.732.443.05
EBIT
-19.36-4.33-5.48-7.8-4.08-1.07-1.2613.212.11-7.887.948.6825.5138.7153.5144.7948.1648.9655.0946.84
EBIT Margin
-26.87%-5.67%-7.21%-10.39%-4.56%-1.01%-1.09%11.10%1.50%-4.67%4.54%4.54%10.81%13.07%15.33%13.28%12.34%10.80%13.19%12.40%
Effective Tax Rate
-----13.74%246.77%37.18%28.45%-28.22%38.43%12.87%22.59%25.05%18.18%24.48%19.84%24.00%27.22%
Advertising Expenses
0.10.20.2-0.71.64.6-4.62.82.5---------
SEC Filings: 10-K · 10-Q